You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 2021377377116
Jun 202134634585
Jul 202116116143
Aug 202115615658
Sep 202111911940
Oct 202113613649
Nov 202112712743
Dec 202113813926
Jan 202210110531
Feb 202212813457
Mar 2022828651
Apr 2022737940
May 2022859953
Jun 202210010546
Jul 2022838739
Aug 202210310436
Sep 2022929234
Oct 2022788831
Nov 2022949446
Dec 2022868732
Jan 2023747422
Feb 2023898919
Mar 2023808131
Apr 2023656523
May 2023686826
Jun 2023535515
Jul 2023777733
Aug 2023848419
Sep 2023626213
Oct 2023848440
Nov 2023888826
Dec 2023838330
Jan 2024525327
Feb 2024696935
Mar 2024898971
Total378238411386